R&D at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's R&D?
- Sana Biotechnology (SANA) reported R&D of $28.72M in Q1 2026.
- How has Sana Biotechnology's R&D changed year-over-year?
- Sana Biotechnology's R&D decreased by 22.8% year-over-year, from $37.19M to $28.72M.
- What is the long-term trend for Sana Biotechnology's R&D?
- Over 4 years (2021 to 2025), Sana Biotechnology's R&D has grown at a -14.6% compound annual growth rate (CAGR), from $248.63M to $131.98M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.